551 related articles for article (PubMed ID: 16627020)
1. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
2. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
3. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
[TBL] [Abstract][Full Text] [Related]
5. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
Osada S; Kanematsu M; Imai H; Goshima S
Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
8. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
Chijiiwa K; Saiki S; Tanaka M
Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
[TBL] [Abstract][Full Text] [Related]
11. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
14. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of hepatocytes].
Annen K
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):301-11. PubMed ID: 8157255
[TBL] [Abstract][Full Text] [Related]
16. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
[TBL] [Abstract][Full Text] [Related]
17. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
[TBL] [Abstract][Full Text] [Related]
18. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy.
Dłuzniewska J; Zolich D; Polański J; Zajac L; Sitkiewicz D; Łukomska B
Med Sci Monit; 2002 Oct; 8(10):CR690-6. PubMed ID: 12388921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]